Medtronic will use the assets to develop PEEK interbody fusion devices. The FDA-designated bone-growth nanotechnology uses osseointegration to enhance implant fixation.
“Combining our market-leading nano surface technology with Medtronic’s market-leading PEEK implant designs will give a growing number of surgeons access to best-in-class devices to treat patients,” Brian More, Nanovis’ CEO, said in the release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
